Key result
Live-attenuated African swine fever virus vaccines raise safety concerns in non-endemic regions due to the virus's genetic instability and potential to regain virulence.
Why the study?
African swine fever virus genome plasticity and recent emergence of live-attenuated vaccine strains causing disease raise concerns regarding diagnostics and vaccine safety.
The genetic instability of the African swine fever virus genome poses significant challenges for diagnostics and raises critical safety concerns for the deployment of live-attenuated vaccines.
Rapid ASFV variant emergence warrants enhanced genomic surveillance in swine; leaves open impacts on vaccine efficacy and outbreak dynamics.
African swine fever (ASF) is a highly contagious transboundary viral hemorrhagic disease of domestic and wild pigs presenting a significant threat to the global swine industry. Following its introduction in Caucasus, Georgia, in 2007, the genome of the genotype II of African swine fever virus (ASFV) strain Georgia-07 and its derivatives accumulated significant mutations, resulting in the emergence of genetic variants within short epidemiological timescales as it spreads and infects different hosts in diverse ecosystems, causing outbreaks in Europe, South Asia, South East Asia and the Caribbean. This suggests that ASFV, with a comparatively large and complex DNA genome, is susceptible to genetic mutations including deletions and that although the virus is environmentally stable, it is genetically unstable. This has implications for the development of vaccines and diagnostic tests for disease detection and surveillance. Analysis of the ASFV genome revealed recombination hotspots, which in double-stranded DNA (dsDNA) viruses represent key drivers of genetic diversity. The ability of pox virus, a dsDNA virus with a genome complexity similar to ASFV, regaining virulence following the deletion of a virulence gene via gene amplification, coupled with the recent emergence and spread of live-attenuated ASFV vaccine strains causing disease and death in pigs in China, raise legitimate concerns around the use of live-attenuated ASFV vaccines in non-endemic regions to control the potential introduction. Further research into the risk of using live-attenuated ASFV in non-endemic regions is highly needed.
No takes yet. Share an insight, caveat, or question.
Bonto Faburay (2022) conducted a review in African swine fever. Live-attenuated ASFV vaccines was evaluated. Live-attenuated African swine fever virus vaccines raise safety concerns in non-endemic regions due to the virus's genetic instability and potential to regain virulence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: